Engineering & Construction
Compare Stocks
5 / 10Stock Comparison
ECG vs WLDN vs PRIM vs MYRG vs PWR
Revenue, margins, valuation, and 5-year total return — side by side.
Engineering & Construction
Engineering & Construction
Engineering & Construction
Engineering & Construction
ECG vs WLDN vs PRIM vs MYRG vs PWR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Engineering & Construction | Engineering & Construction | Engineering & Construction | Engineering & Construction | Engineering & Construction |
| Market Cap | $8.33B | $1.31B | $5.68B | $6.82B | $111.76B |
| Revenue (TTM) | $3.96B | $684M | $7.49B | $3.82B | $29.99B |
| Net Income (TTM) | $223M | $56M | $248M | $142M | $1.12B |
| Gross Margin | 12.4% | 38.2% | 10.4% | 11.9% | 13.6% |
| Operating Margin | 7.4% | 6.5% | 4.9% | 5.1% | 5.8% |
| Forward P/E | 37.8x | 21.4x | 20.2x | 40.3x | 53.5x |
| Total Debt | $106M | $69M | $1.28B | $104M | $1.19B |
| Cash & Equiv. | $171M | $66M | $541M | $150M | $440M |
ECG vs WLDN vs PRIM vs MYRG vs PWR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 24 | May 26 | Return |
|---|---|---|---|
| Everus Construction… (ECG) | 100 | 317.0 | +217.0% |
| Willdan Group, Inc. (WLDN) | 100 | 186.8 | +86.8% |
| Primoris Services C… (PRIM) | 100 | 167.4 | +67.4% |
| MYR Group Inc. (MYRG) | 100 | 334.2 | +234.2% |
| Quanta Services, In… (PWR) | 100 | 246.9 | +146.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECG vs WLDN vs PRIM vs MYRG vs PWR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECG carries the broadest edge in this set and is the clearest fit for growth and momentum.
- 31.5% revenue growth vs MYRG's 8.8%
- +238.2% vs PRIM's +53.5%
- 13.4% ROA vs PWR's 4.8%, ROIC 31.4% vs 11.8%
WLDN ranks third and is worth considering specifically for growth exposure.
- Rev growth 20.5%, EPS growth 120.9%, 3Y rev CAGR 16.7%
- 8.2% margin vs PRIM's 3.3%
PRIM is the #2 pick in this set and the best alternative if valuation efficiency and defensive is your priority.
- PEG 1.10 vs PWR's 3.10
- Beta 1.37, yield 0.3%, current ratio 1.26x
- Lower P/E (20.2x vs 53.5x), PEG 1.10 vs 3.10
- 0.3% yield, 2-year raise streak, vs PWR's 0.1%, (3 stocks pay no dividend)
Among these 5 stocks, MYRG doesn't own a clear edge in any measured category.
PWR is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 7 yrs, beta 1.32, yield 0.1%
- 31.2% 10Y total return vs MYRG's 17.2%
- Lower volatility, beta 1.32, Low D/E 13.2%, current ratio 1.14x
- Beta 1.32 vs ECG's 2.41, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.5% revenue growth vs MYRG's 8.8% | |
| Value | Lower P/E (20.2x vs 53.5x), PEG 1.10 vs 3.10 | |
| Quality / Margins | 8.2% margin vs PRIM's 3.3% | |
| Stability / Safety | Beta 1.32 vs ECG's 2.41, lower leverage | |
| Dividends | 0.3% yield, 2-year raise streak, vs PWR's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +238.2% vs PRIM's +53.5% | |
| Efficiency (ROA) | 13.4% ROA vs PWR's 4.8%, ROIC 31.4% vs 11.8% |
ECG vs WLDN vs PRIM vs MYRG vs PWR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ECG vs WLDN vs PRIM vs MYRG vs PWR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WLDN leads in 1 of 6 categories
PRIM leads 1 • ECG leads 1 • MYRG leads 0 • PWR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
WLDN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PWR is the larger business by revenue, generating $30.0B annually — 43.8x WLDN's $684M. Profitability is closely matched — net margins range from 8.2% (WLDN) to 3.3% (PRIM). On growth, PWR holds the edge at +26.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.0B | $684M | $7.5B | $3.8B | $30.0B |
| EBITDAEarnings before interest/tax | $321M | $64M | $437M | $261M | $2.4B |
| Net IncomeAfter-tax profit | $223M | $56M | $248M | $142M | $1.1B |
| Free Cash FlowCash after capex | $230M | $43M | $165M | $231M | $1.7B |
| Gross MarginGross profit ÷ Revenue | +12.4% | +38.2% | +10.4% | +11.9% | +13.6% |
| Operating MarginEBIT ÷ Revenue | +7.4% | +6.5% | +4.9% | +5.1% | +5.8% |
| Net MarginNet income ÷ Revenue | +5.6% | +8.2% | +3.3% | +3.7% | +3.7% |
| FCF MarginFCF ÷ Revenue | +5.8% | +6.3% | +2.2% | +6.0% | +5.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.4% | +1.8% | -5.4% | +20.0% | +26.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +58.3% | +71.9% | -60.5% | +106.2% | +51.0% |
Valuation Metrics
PRIM leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 20.9x trailing earnings, PRIM trades at a 81% valuation discount to PWR's 109.5x P/E. Adjusting for growth (PEG ratio), PRIM offers better value at 1.14x vs PWR's 6.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.3B | $1.3B | $5.7B | $6.8B | $111.8B |
| Enterprise ValueMkt cap + debt − cash | $8.3B | $1.3B | $6.4B | $6.8B | $112.5B |
| Trailing P/EPrice ÷ TTM EPS | 41.33x | 25.33x | 20.88x | 58.15x | 109.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.76x | 21.44x | 20.22x | 40.31x | 53.49x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.14x | 3.48x | 6.35x |
| EV / EBITDAEnterprise value multiple | 28.16x | 20.87x | 12.69x | 29.55x | 45.32x |
| Price / SalesMarket cap ÷ Revenue | 2.22x | 1.92x | 0.75x | 1.86x | 3.94x |
| Price / BookPrice ÷ Book value/share | 13.26x | 4.37x | 3.42x | 10.43x | 12.51x |
| Price / FCFMarket cap ÷ FCF | 92.57x | 18.50x | 16.69x | 29.36x | 68.95x |
Profitability & Efficiency
ECG leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ECG delivers a 37.2% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $13 for PWR. PWR carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRIM's 0.76x. On the Piotroski fundamental quality scale (0–9), MYRG scores 8/9 vs PWR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +37.2% | +19.4% | +15.2% | +22.1% | +13.0% |
| ROA (TTM)Return on assets | +13.4% | +11.0% | +5.6% | +8.7% | +4.8% |
| ROICReturn on invested capital | +31.4% | +11.5% | +13.6% | +18.3% | +11.8% |
| ROCEReturn on capital employed | +30.0% | +12.4% | +16.3% | +19.4% | +11.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 5 | 8 | 4 |
| Debt / EquityFinancial leverage | 0.17x | 0.23x | 0.76x | 0.16x | 0.13x |
| Net DebtTotal debt minus cash | -$65M | $3M | $735M | -$47M | $748M |
| Cash & Equiv.Liquid assets | $171M | $66M | $541M | $150M | $440M |
| Total DebtShort + long-term debt | $106M | $69M | $1.3B | $104M | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | 16.89x | 12.45x | 21.02x | 39.49x | 6.27x |
Total Returns (Dividends Reinvested)
Evenly matched — WLDN and PWR each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PWR five years ago would be worth $74,205 today (with dividends reinvested), compared to $23,922 for WLDN. Over the past 12 months, ECG leads with a +238.2% total return vs PRIM's +53.5%. The 3-year compound annual growth rate (CAGR) favors WLDN at 73.4% vs MYRG's 48.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +83.0% | -17.1% | -19.7% | +93.1% | +69.4% |
| 1-Year ReturnPast 12 months | +238.2% | +117.9% | +53.5% | +182.4% | +128.4% |
| 3-Year ReturnCumulative with dividends | +233.1% | +421.2% | +333.3% | +227.6% | +341.7% |
| 5-Year ReturnCumulative with dividends | +233.1% | +139.2% | +229.4% | +441.6% | +642.0% |
| 10-Year ReturnCumulative with dividends | +233.1% | +708.7% | +387.5% | +1724.4% | +3118.4% |
| CAGR (3Y)Annualised 3-year return | +49.4% | +73.4% | +63.0% | +48.5% | +64.1% |
Risk & Volatility
Evenly matched — ECG and PWR each lead in 1 of 2 comparable metrics.
Risk & Volatility
PWR is the less volatile stock with a 1.32 beta — it tends to amplify market swings less than ECG's 2.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECG currently trades 95.1% from its 52-week high vs PRIM's 51.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.41x | 2.07x | 1.37x | 1.65x | 1.32x |
| 52-Week HighHighest price in past year | $171.58 | $137.00 | $205.50 | $475.39 | $788.72 |
| 52-Week LowLowest price in past year | $47.12 | $40.26 | $67.15 | $152.93 | $320.56 |
| % of 52W HighCurrent price vs 52-week peak | +95.1% | +64.5% | +51.0% | +92.1% | +94.4% |
| RSI (14)Momentum oscillator 0–100 | 66.5 | 45.0 | 33.2 | 69.1 | 73.6 |
| Avg Volume (50D)Average daily shares traded | 537K | 362K | 1.1M | 297K | 1.1M |
Analyst Outlook
Evenly matched — PRIM and PWR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ECG as "Buy", WLDN as "Buy", PRIM as "Buy", MYRG as "Hold", PWR as "Buy". Consensus price targets imply 57.1% upside for PRIM (target: $165) vs -10.7% for PWR (target: $665). PRIM is the only dividend payer here at 0.30% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $153.60 | $117.50 | $164.63 | $412.67 | $665.29 |
| # AnalystsCovering analysts | 5 | 7 | 23 | 21 | 35 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.3% | — | +0.1% |
| Dividend StreakConsecutive years of raises | — | 0 | 2 | 4 | 7 |
| Dividend / ShareAnnual DPS | — | — | $0.32 | — | $0.40 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | +1.1% | +0.1% |
WLDN leads in 1 of 6 categories (Income & Cash Flow). PRIM leads in 1 (Valuation Metrics). 3 tied.
ECG vs WLDN vs PRIM vs MYRG vs PWR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ECG or WLDN or PRIM or MYRG or PWR a better buy right now?
For growth investors, Everus Construction Group, Inc.
(ECG) is the stronger pick with 31. 5% revenue growth year-over-year, versus 8. 8% for MYR Group Inc. (MYRG). Primoris Services Corporation (PRIM) offers the better valuation at 20. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Everus Construction Group, Inc. (ECG) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECG or WLDN or PRIM or MYRG or PWR?
On trailing P/E, Primoris Services Corporation (PRIM) is the cheapest at 20.
9x versus Quanta Services, Inc. at 109. 5x. On forward P/E, Primoris Services Corporation is actually cheaper at 20. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Primoris Services Corporation wins at 1. 10x versus Quanta Services, Inc. 's 3. 10x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — ECG or WLDN or PRIM or MYRG or PWR?
Over the past 5 years, Quanta Services, Inc.
(PWR) delivered a total return of +642. 0%, compared to +139. 2% for Willdan Group, Inc. (WLDN). Over 10 years, the gap is even starker: PWR returned +31. 2% versus ECG's +233. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECG or WLDN or PRIM or MYRG or PWR?
By beta (market sensitivity over 5 years), Quanta Services, Inc.
(PWR) is the lower-risk stock at 1. 32β versus Everus Construction Group, Inc. 's 2. 41β — meaning ECG is approximately 83% more volatile than PWR relative to the S&P 500. On balance sheet safety, Quanta Services, Inc. (PWR) carries a lower debt/equity ratio of 13% versus 76% for Primoris Services Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ECG or WLDN or PRIM or MYRG or PWR?
By revenue growth (latest reported year), Everus Construction Group, Inc.
(ECG) is pulling ahead at 31. 5% versus 8. 8% for MYR Group Inc. (MYRG). On earnings-per-share growth, the picture is similar: MYR Group Inc. grew EPS 311. 5% year-over-year, compared to 12. 8% for Quanta Services, Inc.. Over a 3-year CAGR, PRIM leads at 19. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECG or WLDN or PRIM or MYRG or PWR?
Willdan Group, Inc.
(WLDN) is the more profitable company, earning 7. 7% net margin versus 3. 2% for MYR Group Inc. — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ECG leads at 7. 1% versus 4. 4% for MYRG. At the gross margin level — before operating expenses — WLDN leads at 37. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECG or WLDN or PRIM or MYRG or PWR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Primoris Services Corporation (PRIM) is the more undervalued stock at a PEG of 1. 10x versus Quanta Services, Inc. 's 3. 10x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Primoris Services Corporation (PRIM) trades at 20. 2x forward P/E versus 53. 5x for Quanta Services, Inc. — 33. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRIM: 57. 1% to $164. 63.
08Which pays a better dividend — ECG or WLDN or PRIM or MYRG or PWR?
In this comparison, PRIM (0.
3% yield) pays a dividend. ECG, WLDN, MYRG, PWR do not pay a meaningful dividend and should not be held primarily for income.
09Is ECG or WLDN or PRIM or MYRG or PWR better for a retirement portfolio?
For long-horizon retirement investors, MYR Group Inc.
(MYRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1724% 10Y return). Everus Construction Group, Inc. (ECG) carries a higher beta of 2. 41 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MYRG: +1724%, ECG: +233. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECG and WLDN and PRIM and MYRG and PWR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ECG is a small-cap high-growth stock; WLDN is a small-cap high-growth stock; PRIM is a small-cap high-growth stock; MYRG is a small-cap quality compounder stock; PWR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.